• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION Back to Search Results
Model Number 2202-0007
Device Problems Fluid/Blood Leak (1250); Material Split, Cut or Torn (4008)
Patient Problem No Code Available (3191)
Event Date 03/21/2019
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical product: 150ml baxter bag container lot dr18k12045.The affected product has been received and the investigation is pending.A follow up report will be submitted once the failure investigation has been completed.
 
Event Description
It was reported that upon entering the infant's room to hang platelets, the nurse discovered a small white puddle on the floor that was determined to be 20% intralipids.The rate of infusion was 4ml/hr to infuse over 20 hours using a 1.2 micron filter.Upon further investigation, the nurse noticed that the lipids where slowly dripping down the pump module.When the nurse opened the channel door a tear in the iv tubing was found to be leaking the lipids.There was "emotional distress or inconvenience" for the patient.
 
Manufacturer Narrative
The customer¿s report that the tubing leaked and had a tear in the iv tubing was not confirmed.Inspection under magnification of the set's components and infusion bag observed no obvious damages or issues.An attempted reprime, infusion ran at the reported rate, and pressure tested of the received set noted no leaks or any issues.Further testing was performed.A lab gauge needle was manually attached to the male luer end of the reprimed set and the set was loaded into a lab pump module.An infusion was programmed to run at the reported rate of 4ml for one hour.The infusion completed as expected with no leaks, alarms, or any issues observed.The set was also pressure tested while submerged underwater.Each of the set's tubing engagements were manipulated as well as the silicone segment component being slightly stretched while the pressure was gradually increased up to 30psi.No leaks or any issues were observed.The root cause was not identified.
 
Event Description
It was reported that upon entering the infant's room to hang platelets, the nurse discovered a small white puddle on the floor that was determined to be 20% intralipids.The rate of infusion was 4ml/hr to infuse over 20 hours using a 1.2 micron filter.Upon further investigation, the nurse noticed that the lipids where slowly dripping down the pump module.When the nurse opened the channel door a tear in the iv tubing was found to be leaking the lipids.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INFUSION
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8562642
MDR Text Key143991936
Report Number9616066-2019-01100
Device Sequence Number1
Product Code FPA
UDI-Device Identifier10885403274039
UDI-Public10885403274039
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 04/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2202-0007
Device Catalogue Number2202-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
THERAPY DATE: (B)(6) 2019
Patient Age18 MO
-
-